(Q28573220)

English

Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling

scientific journal article

In more languages

Statements

scholarly article

1 reference

PubMed publication ID

31 January 2017

Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling (English)

1 reference

PubMed publication ID

31 January 2017

author name string

Jun Cai

1

1 reference

PubMed publication ID

31 January 2017

Fang-Fang Yi

2

1 reference

PubMed publication ID

31 January 2017

Long Yang

3

1 reference

PubMed publication ID

31 January 2017

Di-Fei Shen

4

1 reference

PubMed publication ID

31 January 2017

Qinling Yang

5

1 reference

PubMed publication ID

31 January 2017

Ankang Li

6

1 reference

PubMed publication ID

31 January 2017

Asish K. Ghosh

7

1 reference

PubMed publication ID

31 January 2017

Zhou-Yan Bian

8

1 reference

PubMed publication ID

31 January 2017

Ling Yan

9

1 reference

PubMed publication ID

31 January 2017

Qi-Zhu Tang

10

1 reference

PubMed publication ID

31 January 2017

Hongliang Li

11

1 reference

PubMed publication ID

31 January 2017

Xin-Chun Yang

12

1 reference

PubMed publication ID

31 January 2017

language of work or name

0 references

publication date

1 March 2009

1 reference

PubMed publication ID

31 January 2017

1 reference

PubMed publication ID

31 January 2017

53

1 reference

PubMed publication ID

31 January 2017

3

1 reference

PubMed publication ID

31 January 2017

539–548

1 reference

PubMed publication ID

31 January 2017

Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

19 March 2017

Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

19 March 2017

Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

19 March 2017

Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

19 March 2017

Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

19 March 2017

Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

19 March 2017

Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

19 March 2017

Regulation of cardiac hypertrophy by intracellular signalling pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

7 April 2017

MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

The fuzzy logic of physiological cardiac hypertrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

Recent advances in cardiac development with therapeutic implications for adult cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

Receptor tyrosine kinases are signaling intermediates of G protein-coupled receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

Matrix metalloproteinase-dependent EGF receptor activation in hypertension and left ventricular hypertrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

Pharmacological role of HB-EGF shedding by angiotensin II in cardiomyocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

Hypertrophy of the heart: a new therapeutic target?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

Signalling pathways in cardiac myocyte hypertrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

29 September 2017

Gene 33/RALT is induced by hypoxia in cardiomyocytes, where it promotes cell death by suppressing phosphatidylinositol 3-kinase and extracellular signal-regulated kinase survival signaling.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

3 June 2018

EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

27 November 2018

Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

27 November 2018

Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

27 November 2018

Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

27 November 2018

Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

27 November 2018

Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845399

27 November 2018

An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19204184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19204184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Curcumin prevents and reverses murine cardiac hypertrophy

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI32865

Identifiers

10.1161/HYPERTENSIONAHA.108.120816

1 reference

PubMed publication ID

31 January 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

PubMed publication ID

31 January 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28573220&oldid=2051904188"